Sodium Chloride Inj; Glass particles
Last updated
Summary
Product
Sodium chloride 23.4% Injection
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
---|---|---|---|---|---|
Omega Labs | Sodium Chloride 23.4% Injection | DIN 00402230 | Solution | Sodium chloride 234 mg/mL | 0J970A, 1A106A, 1B134A, 1B142A, 1C175A, 1C184A, 1D191A, 1K340A, 1L370A |
Issue
The affected lots may contain glass particles.
What you should do
Verify if your product is affected.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Omega Laboratories Limited
11177 Hamon,
Montréal QC H3M 3E4 Canada
Published by
Health Canada
Audience
General public
Healthcare
Health professionals
Hospitals
Recall class
Type I
Identification number
RA-64423